UBS Group »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by UBS Group

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6k 670 2.40
2025-06-30 $584 330 1.77
2025-03-31 $535 330 1.62

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Readystate Asset Management
MacKay Shields
Tenor Capital Management
Citadel Advisors
Franklin Resources
Polar Securities
Capstone Investment Advisors
Bnp Paribas Arbitrage, Snc
Point72 Asset Management
FMR
Aristeia Capital
Aequim Alternative Investments
SSI Investment Management
Lord, Abbett & Co

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0